IP Library › Granted Patent US 10,159,654
Granted Patent B2
US 10,159,654 · App. 14/476,555 · Granted Dec 25, 2018

Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof

Inventor: Benny Antony (Ankamaly, IN)
Assignee: ARJUNA NATURAL EXTRACTS, LTD
A61K31/12A61K36/9066
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,159,654
App. No.
14/476,555
Granted
Dec 25, 2018
Kind
B2
Abstract

Disclosure provides a formulation of curcuminoid with essential oil of turmeric to enhance the bioavailability of curcumin and to augment the biological activity of curcumin, wherein curcumin is the main constituent of curcuminoid and wherein Ar-turmerone is the main constituent of the essential oil of turmeric. An application of curcuminoid with essential oil of turmeric to enhance the bioavailability of curcumin for oral supplementation against a variety of diseases and method of doing the same is provided.

Claims (34)

1. A method of treating a central nervous system disorder in a subject in need thereof, the method comprising administering to said subject in need thereof a composition comprising an effective amount of a blend consisting of:

a.) a curcuminoid mixture consisting of curcumin, demethoxycurcumin, and bisdemethoxycurcumin; and

b.) a fraction of essential oil of turmeric comprising 45% ar-turmerone,

wherein the weight ratio of a.) to b.) in the blend is about 1:3 to about 99:1, and

wherein the central nervous system disorder is depression.

2. The method of claim 1 , wherein the weight ratio of a.) to b.) is about 10:1.

3. The method of claim 1 , wherein the weight ratio of a.) to b.) is about 12:1.

4. The method of claim 1 , wherein the effective amount of the blend is about 500 mg.

5. The method of claim 1 , wherein a.) is in an amount of about 454.55 mg.

6. The method of claim 1 , wherein b.) is in an amount of about 45.45 mg.

7. The method of claim 1 , wherein a.) is in an amount of about 461.55 mg.

8. The method of claim 1 , wherein b.) is in an amount of about 38.5 mg.

9. The method of claim 1 , wherein a.) is in an amount of about 454.55 mg, and b.) is in an amount of about 45.45 mg.

10. The method of claim 1 , wherein a,) is in an amount of about 461.5 mg, and b.) is in an amount of about 38.5 mg.

11. The method of claim 1 , wherein the composition is a gelatin capsule.

12. The method of claim 11 , wherein the gelatin capsule comprises 500 mg of the blend.

13. The method of claim 12 , wherein the gelatin capsule is administered twice daily for 8 weeks.

14. The method of claim 1 , wherein administering the composition improves the response rate of the subject on a Hamilton Depression rate scale after two months.

15. The method of claim 14 , wherein the response rate of the subject on the Hamilton Depression rate scale decreases from about 21 to about 7 two months after administering the composition.

16. The method of claim 14 , wherein the response rate of the subject on the Hamilton Depression rate scale improves by about 65% after administering the composition.

17. The method of claim 14 , wherein the response rate of the subject on the Hamilton Depression rate scale improves by about 52% after administering the composition.

18. The method of claim 1 , wherein administering the composition improves the Clinical Global Severity score (CGI-S) of the subject.

19. The method of claim 18 , wherein the Clinical Global Severity score (CGI-S) decreases from about 5 to about 1.

20. The method of claim 18 , wherein the Clinical Global Severity score (CGI-S) improves by about 75%.

21. The method of claim 18 , wherein the Clinical Global Severity score (CGI-S) improves by about 60%.

22. The method of claim 18 , wherein administering the composition improves the Global Change scale (CGI-I) score of the subject.

23. The method of claim 22 , wherein the Global Change scale (CGI-I) score decreases from about 5 to about 2 after administering the composition to the subject.

24. The method of claim 22 , wherein the Global Change scale (CGI-I) score improves about 60% after administering the composition to the subject.

25. The method of claim 22 , wherein the Global Change scale (CGI-I) score improves about 50% after administering the composition to the subject.

26. The method of claim 1 , wherein the blend is prepared by the method comprising:

suspending a.) in water to form a suspension;

adding b.) to the suspension to form a mixture;

homogenizing the mixture to obtain a slurry; and

drying the slurry under heat and vacuum to form the blend.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2016
From: ANTONY, BENNY
To: ARJUNA NATURAL EXTRACTS, LTD.
Reel/Frame 039923/0826 →
Priority Claims (1)
IN 950CHE2010 · Apr 5, 2010 · national
Continuity (16)
Division 13645031 · Oct 4, 2012
Continuation In Part 14094725 · Dec 2, 2013
Continuation In Part 13674249 · Nov 12, 2012
Continuation In Part PCTIN2011000232 · Apr 4, 2011
Continuation In Part 13385717 · Mar 5, 2012
Continuation In Part 13506572 · Apr 30, 2012
Division 13385717 · Mar 5, 2012
Division 12926985 · Dec 21, 2010
Division 12662740 · Apr 30, 2010
Division 11635599 · Dec 8, 2006
Division 13506572 · Apr 30, 2012
Division 12926980 · Dec 21, 2010
Division 12073864 · Mar 11, 2008
Continuation In Part 11635599 · Dec 8, 2006
Continuation PCTIN2005000176 · May 30, 2005
Related Publication 20140371327A1 · Dec 18, 2014
Cited By (1)
US 12,251,415